Breast cancer screening (mammography).
CE Class IIa.
Not the primary source used here.
Third-party industry review citing routine use at the East Midlands Radiology Consortium (NHS).
Cited routine deployment at the East Midlands Radiology Consortium (NHS).
Single named deployment site found — broader NHS uptake not yet quantified.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.